Sectoral Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$371K Sell
1,750
-299
-15% -$52.3K 0.31% 65
2025
Q4
$348K Sell
2,049
-195
-9% -$29.9K 0.28% 65
2025
Q3
$296K Sell
2,244
-30
-1% -$3.6K 0.18% 76
2025
Q2
$241K Hold
2,274
0.16% 81
2025
Q1
$282K Buy
2,274
+524
+30% +$68.4K 0.22% 66
2024
Q4
$216K Sell
1,750
-524
-23% -$61.8K 0.14% 73
2024
Q3
$253K Sell
2,274
-1,060
-32% -$116K 0.15% 84
2024
Q2
$356K Sell
3,334
-560
-14% -$61.6K 0.14% 76
2024
Q1
$469K Sell
3,894
-200
-5% -$24.5K 0.18% 73
2023
Q4
$504K Buy
4,094
+180
+5% +$22.5K 0.22% 79
2023
Q3
$507K Buy
3,914
+580
+17% +$77.3K 0.1% 106
2023
Q2
$413K Buy
3,334
+1,164
+54% +$157K 0.07% 109
2023
Q1
$318K Buy
2,170
+200
+10% +$29.6K 0.06% 108
2022
Q4
$314K Hold
1,970
0.06% 111
2022
Q3
$263K Hold
1,970
0.05% 100
2022
Q2
$307K Buy
+1,970
New +$303K 0.06% 100
2020
Q3
Sell
-8,300
Closed -$916K 139
2020
Q2
$916K Buy
+8,300
New +$918K 0.08% 107
2016
Q1
Sell
-13,550
Closed -$1.91M 87
2015
Q4
$1.91M Buy
13,550
+1,144
+9% +$159K 0.08% 65
2015
Q3
$1.65M Buy
12,406
+458
+4% +$78.9K 0.08% 66
2015
Q2
$2.1M Buy
11,948
+2,543
+27% +$457K 0.09% 61
2015
Q1
$1.63M Buy
+9,405
New +$1.61M 0.06% 61

Other funds holding JAZZ

Sectoral Asset Management's JAZZ Position: Q1 2026 in Review

Sectoral Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 15% in Q1 2026, selling an estimated $52.3K and leaving 1,750 shares worth $371K. The position accounts for 0.31% of the portfolio, ranked #65.

Sectoral Asset Management first reported a position in JAZZ in Q1 2015 and has held it in 21 quarters since. The position peaked at $2.1M in Q2 2015. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Sectoral Asset Management held 1,750 shares of Jazz Pharmaceuticals worth $371K as of Q1 2026.
  • Sectoral Asset Management sold 299 Jazz Pharmaceuticals shares in Q1 2026, an estimated $52.3K.
  • Jazz Pharmaceuticals made up 0.31% of Sectoral Asset Management's portfolio in Q1 2026, its #65 holding.
  • Sectoral Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2015 and has held it in 21 quarters since.
  • Sectoral Asset Management's Jazz Pharmaceuticals position peaked at $2.1M in Q2 2015.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Sectoral Asset Management's 13F filing for Q1 2026, filed 15 May 2026.